<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00679952</url>
  </required_header>
  <id_info>
    <org_study_id>H-0612-018-191</org_study_id>
    <nct_id>NCT00679952</nct_id>
  </id_info>
  <brief_title>Closed Suction Drainage and Natural Drainage of the Pancreatic Duct in Pancreaticojejunostomy</brief_title>
  <official_title>Randomised Prospective Study of Clinical Outcomes After Closed Suction Drainage and Natural Drainage of the Pancreatic Duct in Pancreaticojejunostomy After Pancreatoduodenectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pancreaticojejunal anastomosis leakage is a major complication after pancreatoduodenectomy
      and various technical methods have been examined to improve the situation.However, none of
      methods have been successful at improving results according to the findings of prospective
      randomized studies. We propose that active drainage of pancreatic juice using suction
      drainage might maximize the advantage of a stent and finally reduce pancreaticojejunal
      anastomosis leakage.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pancreaticojejunal anastomosis leakage is a major complication after pancreatoduodenectomy
      and various technical methods have been examined to improve the situation, e.g., pancreatic
      duct occlusion, anastomosis reinforcement with fibrin glue, placement of an internal stent,
      and pancreaticogastrostomy. However, none of these methods have been successful at improving
      results according to the findings of prospective randomized studies. Some retrospective
      studies have reported a low pancreatic fistula rate when a catheter is inserted into the
      pancreatic duct to externally drain pancreatic juice. Furthermore, a recent prospective
      randomized trial showed that external drainage of the pancreatic duct decreased the rate of
      pancreatic fistula formation indicating that diverting pancreatic juice from an anastomosis
      can theoretically reduce the incidence of pancreaticojejunostomy anastomotic leakage. We
      propose that active drainage of pancreatic juice using suction drainage might maximize the
      advantage of a stent and finally reduce pancreaticojejunal anastomosis leakage.

      We will enroll all patients who underwent duct-to-mucosa pancreaticojejunostomy
      reconstruction after pancreatoduodenectomy, and randomly allocate them to two groups of
      closed suction drainage group (CD group) and natural drainage group (ND group) just after
      operations.

      Preoperative demographic and clinical data, and surgical procedure, pathologic diagnosis,
      postoperative course and complications details were collected prospectively.

      The primary study endpoints were; pancreatic fistula rates, severity of pancreatic fistulas,
      postoperative complications, postoperative length of hospital stay, and hospital mortality
      rate. Pancreatic fistula was defined as any measurable drainage from an operatively placed
      drain (or a subsequently placed percutaneous drain) on or after postoperative day 3, with an
      amylase content greater than 3 times the upper limit of normal serum amylase level (i.e.,
      &gt;300 IU/L)(International Study Group for Pancreatic Fistulas (ISGPF) definition) or on or
      after postoperative week 1 drainage of more than 30 mL of fluid with an amylase level higher
      than 600 U/dL(Seoul National University Hospital (SNUH) definition). In addition, fistula
      severity was graded as A, B, C according to ISGPF clinical criteria as follows; grade A
      fistula - a transient, asymptomatic fistula with only elevated drain amylase levels and
      treatments or deviation in clinical management are not required; grade B fistula - a
      symptomatic, clinically apparent fistula requiring diagnostic evaluation and therapeutic
      management; and grade C fistula - a severe, clinically significant fistula requiring a major
      deviations in clinical management and unequivocal aggressive therapeutic interventions. Major
      pancreatic leakage was defined as drainage of more than 200 mL of fluid or the development of
      an intra-abdominal abscess.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2007</start_date>
  <completion_date type="Actual">March 2010</completion_date>
  <primary_completion_date type="Actual">March 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Patients With Pancreatic Fistula</measure>
    <time_frame>postoperative 1 week</time_frame>
    <description>pancreatic fistula rate is stratified according to ISGPF criteria.
Grade A; No major impact Grade B; Clinically relevant fistula, specific treatment may be required Grade C; Most severe form of fistula, with a high mortality rate</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Severity of Pancreatic Fistulas</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">168</enrollment>
  <condition>Pancreatic Fistula</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>closed suction drainage group (CD group)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>natural drainage group (ND group)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>closed suction drainage of pancreatic duct</intervention_name>
    <description>A Fr 5-8 silastic polyethylene pediatric feeding tube with multiple side-holes is inserted 2 cm into the pancreatic duct. The catheter exited via a small enterotomy in the jejunal loop of the distal portion of the hepaticojejunostomy. Totally externalized pancreatic stents were connected to the aspiration bag of a Jackson-Pratt drain to generate negative pressure or to a bile bag for natural drainage.</description>
    <arm_group_label>1</arm_group_label>
    <other_name>pancreaticojejunostomy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>natural drainage of pancreatic duct</intervention_name>
    <description>Natural drainage group</description>
    <arm_group_label>2</arm_group_label>
    <other_name>pancreaticojejunostomy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients who undergo duct-to-mucosa pancreaticojejunostomy reconstruction after
             pancreatoduodenectomy in our institution

        Exclusion criteria:

          -  less than 15 years old, or older than 85 years old
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sun-Whe Kim, MD., PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Hamanaka Y, Suzuki T. Total pancreatic duct drainage for leakproof pancreatojejunostomy. Surgery. 1994 Jan;115(1):22-6.</citation>
    <PMID>8284756</PMID>
  </reference>
  <reference>
    <citation>Mok KT, Wang BW, Liu SI. Management of pancreatic remnant with strategies according to the size of pancreatic duct after pancreaticoduodenectomy. Br J Surg. 1999 Aug;86(8):1018-9.</citation>
    <PMID>10460636</PMID>
  </reference>
  <reference>
    <citation>Poon RT, Fan ST, Lo CM, Ng KK, Yuen WK, Yeung C, Wong J. External drainage of pancreatic duct with a stent to reduce leakage rate of pancreaticojejunostomy after pancreaticoduodenectomy: a prospective randomized trial. Ann Surg. 2007 Sep;246(3):425-33; discussion 433-5.</citation>
    <PMID>17717446</PMID>
  </reference>
  <reference>
    <citation>Lee SE, Yang SH, Jang JY, Kim SW. Pancreatic fistula after pancreaticoduodenectomy: a comparison between the two pancreaticojejunostomy methods for approximating the pancreatic parenchyma to the jejunal seromuscular layer: interrupted vs continuous stitches. World J Gastroenterol. 2007 Oct 28;13(40):5351-6.</citation>
    <PMID>17879405</PMID>
  </reference>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 15, 2008</study_first_submitted>
  <study_first_submitted_qc>May 16, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 19, 2008</study_first_posted>
  <results_first_submitted>March 13, 2011</results_first_submitted>
  <results_first_submitted_qc>April 13, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 9, 2011</results_first_posted>
  <last_update_submitted>May 8, 2014</last_update_submitted>
  <last_update_submitted_qc>May 8, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 19, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pancreatic fistula</keyword>
  <keyword>Pancreatic duct stent</keyword>
  <keyword>Closed suction drainage</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fistula</mesh_term>
    <mesh_term>Pancreatic Fistula</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Closed Suction Drainage Group</title>
          <description>closed suction drainage group (CD group)</description>
        </group>
        <group group_id="P2">
          <title>Natural Drainage Group</title>
          <description>natural drainage group (ND group)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="86"/>
                <participants group_id="P2" count="82"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="86"/>
                <participants group_id="P2" count="82"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Closed Suction Drainage Group</title>
          <description>closed suction drainage group (CD group)</description>
        </group>
        <group group_id="B2">
          <title>Natural Drainage Group</title>
          <description>natural drainage group (ND group)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="86"/>
            <count group_id="B2" value="82"/>
            <count group_id="B3" value="168"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="59"/>
                    <measurement group_id="B2" value="49"/>
                    <measurement group_id="B3" value="108"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60.7" spread="10.1"/>
                    <measurement group_id="B2" value="61.4" spread="11.1"/>
                    <measurement group_id="B3" value="61.2" spread="10.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49"/>
                    <measurement group_id="B2" value="55"/>
                    <measurement group_id="B3" value="104"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Korea, Republic of</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="86"/>
                    <measurement group_id="B2" value="82"/>
                    <measurement group_id="B3" value="168"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Patients With Pancreatic Fistula</title>
        <description>pancreatic fistula rate is stratified according to ISGPF criteria.
Grade A; No major impact Grade B; Clinically relevant fistula, specific treatment may be required Grade C; Most severe form of fistula, with a high mortality rate</description>
        <time_frame>postoperative 1 week</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Closed Suction Drainage Group</title>
            <description>closed suction drainage group (CD group)</description>
          </group>
          <group group_id="O2">
            <title>Natural Drainage Group</title>
            <description>natural drainage group (ND group)</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients With Pancreatic Fistula</title>
          <description>pancreatic fistula rate is stratified according to ISGPF criteria.
Grade A; No major impact Grade B; Clinically relevant fistula, specific treatment may be required Grade C; Most severe form of fistula, with a high mortality rate</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="86"/>
                <count group_id="O2" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Severity of Pancreatic Fistulas</title>
        <time_frame>2 years</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Closed Suction Drainage Group</title>
          <description>closed suction drainage group (CD group)</description>
        </group>
        <group group_id="E2">
          <title>Natural Drainage Group</title>
          <description>natural drainage group (ND group)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="82"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="82"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Clinical instructor</name_or_title>
      <organization>Seoul National University College of Medicine</organization>
      <phone>82-2-2072-2817</phone>
      <email>meejookang@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

